Clarity Pharmaceuticals is Drug Discovery in Australia that focus on Clarity Pharmaceuticals Ltd business. Founded in 2010. They cover business area such as Clarity Pharmaceuticals Ltd, next-generation theranostic, therapy, imaging, ) product, its platform SAR Technology, use, copper isotope, radiopharmaceutical product, logistical limitation, oncology.
2010
( 14 years old in 2024 )
Clarity Pharmaceuticals Ltd
-
2-4 Cornwallis Street
National Innovation Centre, Suite 212a
Eveleigh, New South Wales 2015
Australia
Private
Clarity Pharmaceuticals Ltdnext-generation theranostictherapyimaging) productits platform SAR Technologyusecopper isotoperadiopharmaceutical productlogistical limitationoncology
* We use standard office opening hours in near Clarity Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Clarity Pharmaceuticals is Drug Discovery business from Australia that founded in 2010 (14 years old in 2024), Clarity Pharmaceuticals business is focusing on Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals headquarter office and corporate office address is located in 2-4 Cornwallis Street National Innovation Centre, Suite 212a Eveleigh, New South Wales 2015 Australia.
Clarity Pharmaceuticals was founded in Australia.
In 2024, Clarity Pharmaceuticals is currently focus on Clarity Pharmaceuticals Ltd sector.
Above is snippet of Google Trends for "Clarity Pharmaceuticals Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Clarity Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
